Also known as: Aredia (brand); Disodium pamidronate; APD disodium
Pamidronate Disodium is a bisphosphonate that inhibits osteoclast-mediated bone resorption. It is used in the treatment of hypercalcemia of malignancy, Paget's disease of bone, and osteolytic lesions of multiple myeloma and breast cancer. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.
| Parameter | Specification |
|---|---|
| CAS Number | 158749-09-6 |
| Molecular Formula | C22H30N2Na2O12P2 |
| Molecular Weight | 617.43 g/mol |
| Grade | IP / BP / USP |
| Category | Bisphosphonate / Bone Resorption Inhibitor |
| Appearance | White to off-white crystalline powder |
| Solubility | Freely soluble in water, slightly soluble in ethanol |
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No | PAD/24032026 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Pamidronate Disodium — CAS 158749-09-6 (CAS 158749-09-6) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Pamidronate Disodium — CAS 158749-09-6 is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing — identity (IR/HPLC), assay, related substances, residual solvents (ICH Q3C), heavy metals, and microbial limits — before release with a Certificate of Analysis.
Export Markets
Quality & Compliance